Thiazol-5-ylmethyl ((2S,3S,5S)-5-((S)-2-amino-3-methylbutanamido)-3-hydroxy-1,6-diphenylhexan-2-yl)carbamate;Ritonavir EP Impurity D;Ritonavir Impurity 2(Ritonavir EP Impurity B);Ritonavir EP Impurity B DiHCl (Monoacyl Valine DiHCl);Ritonavir EP Impurity B;Ritonavir EP Impurity B DiHCl;[4-[(2-Amino-3-methyl-1-oxobutyl)amino]-2-hydroxy-5-phenyl-1-(phenylmethyl)
pentyl]-carbamic Acid 5-Thiazolylmethyl Ester;Thiazol-5-ylmethyl-[(1S,2S,4S)-4-[[(2S)-2-amino-3-methylbutanoyl]amino]-1-benzyl-2-hydroxy-5-phenylp
[4-[(2-Amino-3-methyl-1-oxobutyl)amino]-2-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-carbamic Acid 5-Thiazolylmethyl Ester, is an intermediate that can be used for the synthesis of Ritonavir (R535000), which is a selective HIV protease inhibitor.
Ritonavir EP Impurity B Preparation Products And Raw materials
